OPTOSURGICAL, LLC - ARPA-H SBIR PHASE II TOPIC 4 FOR INTRA-OPERATIVE CONTRAST AGENTS

On Feb 3, 2026, Department of Health and Human Services obligated $3,500,000 to OPTOSURGICAL, LLC for arpa-h sbir phase ii topic 4 for intra-operative contrast agents. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources with 2 offers received. The procurement used a SMALL BUSINESS SET ASIDE - TOTAL set-aside. Performance is located in COLUMBIA, MD.